Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus

被引:40
|
作者
Moore, Erica [1 ]
Huang, Michelle W. [1 ]
Putterman, Chaim [1 ,2 ,3 ]
机构
[1] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Div Rheumatol, F701N,1300 Morris Pk Ave, Bronx, NY 10461 USA
[3] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel
基金
美国国家卫生研究院;
关键词
angiotensin-converting enzyme inhibitors; biomarkers; microglial activation; neuroimaging; neuropsychiatric lupus; systemic lupus erythematosus; BLOOD-BRAIN-BARRIER; AUTOANTIBODY; DAMAGES;
D O I
10.1097/BOR.0000000000000682
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Diagnosing and treating neuropsychiatric systemic lupus erythematosus (NPSLE) remains challenging as the pathogenesis is still being debated. In this review, we discuss studies evaluating recent advances in diagnostic methods, pathogenic mediators and potential treatments. Recent findings Screening tools used for neurodegenerative diseases were found to be both sensitive and moderately specific for cognitive dysfunction in NPSLE. Neuroimaging can be used to distinguish systemic lupus erythematosus (SLE) patients from healthy controls, but further refinement is needed to differentiate between lupus patients with and without neuropsychiatric manifestations. Elevated levels of specific molecules in the cerebrospinal fluid and/or serum, as well as the presence of certain autoantibodies, have been identified as potential biomarkers in attempts to facilitate a more accurate and objective diagnosis. Among such autoantibodies, anti-NR2 and anti-ribosomal P autoantibodies also have a pathogenic role, although newer studies demonstrate that blood-brain barrier damage may not always be required as previously believed. These and other observations, together with new evidence for disease attenuation after microglial modulation, suggest direct involvement of the central nervous system in NPSLE pathogenesis. Neuropsychiatric involvement of SLE includes a variety of symptoms that impact quality of life and patient prognosis. There have been recent advances in improving the diagnosis of NPSLE as well as in dissecting the underlying pathogenesis. The attenuation of neuropsychiatric disease in mouse models demonstrates the potential for targeted therapies, which are based on a clearer understanding of the pathogenesis of NPSLE. Further assessment of these treatments is required in NPSLE patients, as well as the potential use of neuroimaging to distinguish between SLE patients with or without neuropsychiatric manifestations.
引用
收藏
页码:152 / 158
页数:7
相关论文
共 50 条
  • [41] ADVANCES AND PROSPECTS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Ivanova, M. M.
    Solovyeva, S. K.
    [J]. TERAPEVTICHESKII ARKHIV, 2009, 81 (12): : 44 - 47
  • [42] Recent advances in the involvement of epigenetics in the pathogenesis of systemic lupus erythematosus
    Zhou, Hong-Yan
    Luo, Qi
    Sui, Hua
    Du, Xiang-Ning
    Zhao, Yang-Jianing
    Liu, Lu
    Guan, Qing
    Zhou, Yue
    Wen, Qing-Si
    Shi, Yan
    Sun, Yu
    Lin, Hong-Li
    Wang, Da-Peng
    [J]. CLINICAL IMMUNOLOGY, 2024, 258
  • [43] Recent advances in pathogenesis, diagnosis, and therapeutic approaches for digestive system involvement in systemic lupus erythematosus
    Zhou, Liang
    Cai, Shao Zhe
    Dong, Ling Li
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2024,
  • [44] Neuropsychiatric Systemic Lupus Erythematosus in Children
    Soybilgic, Arzu
    [J]. PEDIATRIC ANNALS, 2015, 44 (06): : E153 - E158
  • [45] Neuropsychiatric manifestations of systemic lupus erythematosus
    Bruns, Alessandra
    Meyer, Olivier
    [J]. JOINT BONE SPINE, 2006, 73 (06) : 639 - 645
  • [46] Neuropsychiatric disorders in systemic lupus erythematosus
    Pizova, N. V.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (08) : 76 - 83
  • [47] Neuropsychiatric questionnaires in systemic lupus erythematosus
    Tani, C.
    Palagini, L.
    Moraes-Fontes, M. F.
    Carli, L.
    Mauri, M.
    Bombardieri, S.
    Mosca, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : S59 - S64
  • [48] Neuropsychiatric syndrome in systemic lupus erythematosus
    Sánchez, CS
    Castillo, J
    Santibañez, R
    [J]. REVISTA ECUATORIANA DE NEUROLOGIA, 2005, 14 (1-3): : 64 - 69
  • [49] SYSTEMIC LUPUS ERYTHEMATOSUS: NEUROPSYCHIATRIC MANIFESTATIONS
    Monov, S.
    Monova, D.
    Rashkov, R.
    Shumnalieva, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1078 - 1078
  • [50] Systemic lupus erythematosus and neuropsychiatric syndromes
    Rachel Murphy
    [J]. Nature Clinical Practice Rheumatology, 2005, 1 (1): : 11 - 11